Adjuvant therapy in colorectal cancer. A randomized trial comparing radio-chemotherapy and radio-chemotherapy combined with methanol extraction residue of BCG, MER

E. Robinson; A. Bartal; Y. Cohen; D. Milstein; T. Mekori

Adjuvant therapy in colorectal cancer. A randomized trial comparing radio-chemotherapy and radio-chemotherapy combined with methanol extraction residue of BCG, MER

E. Robinson, A. Bartal, Y. Cohen, D. Milstein, T. Mekori

Research output: Contribution to journal › Article › peer-review

Abstract

Fifty-three patients with colorectal cancer (Dukes' B ₂ and C) were randomized after surgery. One group was treated by radio-and/or chemotherapy and the second by radio-and/or chemotherapy and MER. After 24 and 36 months a significant longer disease free interval, lower recurrence rate and better survival was found in the group treated by radio-chemo-and immunotherapy. Treatment was well tolerated and there were few local side effects from the MER injections. The long time efficacy of this adjuvant treatment whether it increases the cure rate or only delays recurrence requires longer follow-up.

Original language	English (US)
Pages (from-to)	8-10
Number of pages	3
Journal	Biomedicine Express
Volume	31
Issue number	1
State	Published - 1979
Externally published	Yes

ASJC Scopus subject areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{bba44b68299042f3ab1177811eaadafc,

title = "Adjuvant therapy in colorectal cancer. A randomized trial comparing radio-chemotherapy and radio-chemotherapy combined with methanol extraction residue of BCG, MER",

abstract = "Fifty-three patients with colorectal cancer (Dukes' B 2 and C) were randomized after surgery. One group was treated by radio-and/or chemotherapy and the second by radio-and/or chemotherapy and MER. After 24 and 36 months a significant longer disease free interval, lower recurrence rate and better survival was found in the group treated by radio-chemo-and immunotherapy. Treatment was well tolerated and there were few local side effects from the MER injections. The long time efficacy of this adjuvant treatment whether it increases the cure rate or only delays recurrence requires longer follow-up.",

author = "E. Robinson and A. Bartal and Y. Cohen and D. Milstein and T. Mekori",

year = "1979",

language = "English (US)",

volume = "31",

pages = "8--10",

journal = "Biomedicine Express",

issn = "0300-0885",

publisher = "Masson Publishing",

number = "1",

}

TY - JOUR

T1 - Adjuvant therapy in colorectal cancer. A randomized trial comparing radio-chemotherapy and radio-chemotherapy combined with methanol extraction residue of BCG, MER

AU - Robinson, E.

AU - Bartal, A.

AU - Cohen, Y.

AU - Milstein, D.

AU - Mekori, T.

PY - 1979

Y1 - 1979

N2 - Fifty-three patients with colorectal cancer (Dukes' B 2 and C) were randomized after surgery. One group was treated by radio-and/or chemotherapy and the second by radio-and/or chemotherapy and MER. After 24 and 36 months a significant longer disease free interval, lower recurrence rate and better survival was found in the group treated by radio-chemo-and immunotherapy. Treatment was well tolerated and there were few local side effects from the MER injections. The long time efficacy of this adjuvant treatment whether it increases the cure rate or only delays recurrence requires longer follow-up.

AB - Fifty-three patients with colorectal cancer (Dukes' B 2 and C) were randomized after surgery. One group was treated by radio-and/or chemotherapy and the second by radio-and/or chemotherapy and MER. After 24 and 36 months a significant longer disease free interval, lower recurrence rate and better survival was found in the group treated by radio-chemo-and immunotherapy. Treatment was well tolerated and there were few local side effects from the MER injections. The long time efficacy of this adjuvant treatment whether it increases the cure rate or only delays recurrence requires longer follow-up.

UR - http://www.scopus.com/inward/record.url?scp=0018760656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018760656&partnerID=8YFLogxK

M3 - Article

C2 - 383171

AN - SCOPUS:0018760656

SN - 0300-0885

VL - 31

SP - 8

EP - 10

JO - Biomedicine Express

JF - Biomedicine Express

IS - 1

ER -

Adjuvant therapy in colorectal cancer. A randomized trial comparing radio-chemotherapy and radio-chemotherapy combined with methanol extraction residue of BCG, MER

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this